CARLOS MORENO: Open Payments
NPI 1477615862 · VILLA RICA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 14 payments from 9 companies in 2025. Trend: 2023 $690 · 2024 $130 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $151 |
| Organon LLC | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| GENZYME CORPORATION | 1 | $35 |
| Ionis Pharmaceuticals, Inc. | 1 | $34 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Optinose US, Inc. | 1 | $24 |
Products named: TEZSPIRE, DUPIXENT, AIRSUPRA, VTAMA, DAWNZERA, NEFFY, CUVITRU, Xhance.
Industry payments across GA — which companies pay providers there.
